abstract
- "PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers". Contact PI Eduardo Vliar-Sanchez (MD Anderson Cancer Center); MPI Florencia McAllister (MD Anderson Cancer Center); MPI Roderick Dashwood (Texas A&M Health and School of Medicine)